Development Level

Tbio 22 | 11,651
Tchem 2 | 1,388
Tclin 2 | 612
Tdark 2 | 6,593

IMPC Phenotype

decreased hemoglobin content 2 | 68
increased total body fat amoun... 2 | 134
preweaning lethality, complete... 2 | 979
abnormal bone mineralization 1 | 38
abnormal bone structure 1 | 187
abnormal digit morphology 1 | 10
abnormal gait 1 | 69
abnormal maxilla morphology 1 | 17
decreased IgG3 level 1 | 1
decreased body weight 1 | 161
decreased bone mineral density 1 | 126
decreased circulating alkaline... 1 | 46
decreased circulating choleste... 1 | 93
decreased circulating free fat... 1 | 31
decreased circulating triglyce... 1 | 79
decreased erythrocyte cell num... 1 | 62
decreased hematocrit 1 | 46
decreased large unstained cell... 1 | 11
decreased lean body mass 1 | 135
decreased leukocyte cell numbe... 1 | 73
decreased lymphocyte cell numb... 1 | 83
decreased mature B cell number 1 | 7
decreased mean corpuscular hem... 1 | 50
decreased mean corpuscular vol... 1 | 79
increased IgG1 level 1 | 1
increased IgM level 1 | 1
increased T cell number 1 | 6
increased blood urea nitrogen ... 1 | 48
increased erythrocyte cell num... 1 | 39
increased lean body mass 1 | 172
increased monocyte cell number 1 | 63
increased neutrophil cell numb... 1 | 46
increased spleen weight 1 | 10
preweaning lethality, incomple... 1 | 499
thrombocytopenia 1 | 56

Disease

Carcinoma 22 | 11,493
psoriasis 15 | 6,694
lung cancer 13 | 4,740
ovarian cancer 12 | 8,520
intraductal papillary-mucinous neoplasm (IPMN) 11 | 3,291
lung adenocarcinoma 11 | 2,716
osteosarcoma 11 | 7,950
pancreatic cancer 11 | 2,398
Breast cancer 10 | 3,578
Cancer 10 | 2,499
intraductal papillary-mucinous carcinoma (IPMC) 9 | 2,989
lung carcinoma 9 | 2,843
intraductal papillary-mucinous adenoma (IPMA) 8 | 2,955
ulcerative colitis 8 | 1,819
Kidney cancer 7 | 2,613
cystic fibrosis 7 | 1,696
interstitial cystitis 7 | 2,312
medulloblastoma, large-cell 7 | 6,241
nasopharyngeal carcinoma 7 | 1,058
non-small cell lung cancer 7 | 2,890
Liver cancer 6 | 604
esophageal adenocarcinoma 6 | 737
Large intestine cancer 5 | 126
active ulcerative colitis 5 | 764
adult high grade glioma 5 | 3,801
glioblastoma 5 | 5,792
invasive ductal carcinoma 5 | 2,951
primary Sjogren syndrome 5 | 735
Adenoma 4 | 167
Asthma 4 | 385
Astrocytoma, Pilocytic 4 | 3,081
Biliary papillomatosis 4 | 4
Endometrial cancer 4 | 311
Otitis Media 4 | 52
active Crohn's disease 4 | 922
breast carcinoma 4 | 1,638
colon cancer 4 | 1,478
dermatomyositis 4 | 966
diabetes mellitus 4 | 1,728
group 3 medulloblastoma 4 | 4,104
malignant mesothelioma 4 | 3,232
mucosa-associated lymphoid tissue lymphoma 4 | 484
subependymal giant cell astrocytoma 4 | 2,287
tuberculosis 4 | 2,010
Chronic Lymphocytic Leukemia 3 | 262
Gastritis 3 | 47
Immune system cancer 3 | 140
Liver Cirrhosis, Experimental 3 | 769
Lymphoid leukemia 3 | 160
Melanoma 3 | 711
Multiple myeloma 3 | 1,332
Stomach Neoplasms 3 | 300
Waldenstrons macroglobulinemia 3 | 765
astrocytoma 3 | 1,146
gastric carcinoma 3 | 807
head and neck cancer and chronic obstructive pulmonary disease 3 | 239
interstitial lung disease 3 | 298
non primary Sjogren syndrome sicca 3 | 891
spina bifida 3 | 1,074
urothelial carcinoma 3 | 318
Allergic hypersensitivity disease 2 | 126
Allergic rhinitis 2 | 95
Alzheimer's disease 2 | 658
Anemia 2 | 365
Atopic dermatitis 2 | 952
Blastic phase chronic myeloid leukemia 2 | 58
Bronchiolitis 2 | 18
Bronchitis 2 | 43
Cherubism 2 | 13
Chromoblastomycosis 2 | 10
Chronic Myelocytic Leukemia Accelerated Phase 2 | 59
Chronic obstructive pulmonary disease 2 | 184
Common cold 2 | 69
Common wart 2 | 5
Crohn's disease 2 | 321
DOID:2627 2 | 94
DOID:9917 2 | 31
Down syndrome 2 | 499
Dry eye syndrome 2 | 18
ENSP00000256078 2 | 30
Filamentary keratitis 2 | 5
Gastrointestinal system disease 2 | 54
Inflammatory Bowel Diseases 2 | 35
Lung diseases 2 | 50
Lupus erythematosus 2 | 57
Mesothelioma 2 | 38
Multiple Sclerosis 2 | 540
Pneumonia 2 | 174
Sinusitis 2 | 65
Systemic scleroderma 2 | 60
Vitiligo 2 | 73
cutaneous lupus erythematosus 2 | 1,057
ductal carcinoma in situ 2 | 1,745
juvenile dermatomyositis 2 | 1,187
pancreatic ductal adenocarcinoma liver metastasis 2 | 1,962
periodontitis 2 | 293
pituitary cancer 2 | 1,972
Brain Injuries 1 | 65
Lymphoma, T-Cell, Peripheral 1 | 9
Pityriasis versicolor 1 | 19

Tissue

Digestive Tract 25 | 17,369
Skin and soft tissues 24 | 17,230
Female tissues 23 | 17,400
Blood and immune system 21 | 16,909
Endocrine System 21 | 18,159
Respiratory system 21 | 16,393
Liver and Pancreas 20 | 16,750
Urinary Tract 20 | 16,678
Male tissues 18 | 17,142
Nervous System 15 | 16,725
Cardiovascular System 13 | 15,192

Target Family

Non-IDG 24 | 12,091
Kinase 3 | 634
Enzyme 1 | 4,145

Reactome Pathway

Dectin-2 family 28 | 28
Signal Transduction 2,657 | 2,657
Immune System 2,101 | 2,101
Metabolism of proteins 2,091 | 2,091
Metabolism 2,081 | 2,081
Post-translational protein mod... 1,398 | 1,398
Gene expression (Transcription... 1,369 | 1,369
RNA Polymerase II Transcriptio... 1,228 | 1,228
Signaling by GPCR 1,217 | 1,217
Innate Immune System 1,176 | 1,176
GPCR downstream signalling 1,157 | 1,157
Generic Transcription Pathway 1,108 | 1,108
Developmental Biology 1,026 | 1,026
Adaptive Immune System 892 | 892
Disease 879 | 879
Cytokine Signaling in Immune s... 752 | 752
Metabolism of lipids 739 | 739
Vesicle-mediated transport 720 | 720
Transport of small molecules 717 | 717
Metabolism of RNA 682 | 682
Hemostasis 666 | 666
Membrane Trafficking 608 | 608
Cell Cycle 590 | 590
G alpha (s) signalling events 574 | 574
Neutrophil degranulation 539 | 539
Axon guidance 533 | 533
Cell Cycle, Mitotic 488 | 488
Cellular responses to external... 463 | 463
GPCR ligand binding 459 | 459
Signaling by Interleukins 448 | 448
Class I MHC mediated antigen p... 435 | 435
Signaling by Receptor Tyrosine... 430 | 430
Olfactory Signaling Pathway 428 | 428
Infectious disease 404 | 404
G alpha (i) signalling events 394 | 394
Cellular responses to stress 386 | 386
Signaling by Rho GTPases 386 | 386
Metabolism of amino acids and ... 370 | 370
Diseases of signal transductio... 367 | 367
Neuronal System 367 | 367
Transcriptional Regulation by ... 365 | 365
M Phase 344 | 344
Class A/1 (Rhodopsin-like rece... 322 | 322
Antigen processing: Ubiquitina... 306 | 306
Extracellular matrix organizat... 297 | 297
Translation 297 | 297
Signaling by WNT 293 | 293
Intracellular signaling by sec... 289 | 289
DNA Repair 288 | 288
Asparagine N-linked glycosylat... 287 | 287
MAPK family signaling cascades 285 | 285
Deubiquitination 276 | 276
Interferon Signaling 275 | 275
Immunoregulatory interactions ... 272 | 272
Metabolism of carbohydrates 271 | 271
Cell Cycle Checkpoints 270 | 270
Organelle biogenesis and maint... 261 | 261
PIP3 activates AKT signaling 259 | 259
RHO GTPase Effectors 257 | 257
Platelet activation, signaling... 256 | 256
HIV Infection 254 | 254
MAPK1/MAPK3 signaling 244 | 244
SLC-mediated transmembrane tra... 243 | 243
Processing of Capped Intron-Co... 238 | 238
RAF/MAP kinase cascade 238 | 238
Chromatin modifying enzymes 236 | 236
Chromatin organization 236 | 236
Neddylation 234 | 234
Transmission across Chemical S... 221 | 221
Biological oxidations 220 | 220
Signaling by ROBO receptors 219 | 219
Keratinization 216 | 216
rRNA processing 216 | 216
G alpha (q) signalling events 211 | 211
Cell surface interactions at t... 210 | 210
Phospholipid metabolism 209 | 209
Fc epsilon receptor (FCERI) si... 204 | 204
Transcriptional regulation by ... 203 | 203
Ub-specific processing proteas... 203 | 203
TCF dependent signaling in res... 199 | 199
Muscle contraction 198 | 198
rRNA processing in the nucleus... 192 | 192
Metabolism of vitamins and cof... 188 | 188
Peptide ligand-binding recepto... 188 | 188
mRNA Splicing 187 | 187
Cilium Assembly 186 | 186
Intra-Golgi and retrograde Gol... 186 | 186
Mitotic G2-G2/M phases 184 | 184
Mitotic Metaphase and Anaphase 183 | 183
G2/M Transition 182 | 182
Major pathway of rRNA processi... 182 | 182
Mitotic Anaphase 182 | 182
Mitotic Prometaphase 181 | 181
Fatty acid metabolism 180 | 180
mRNA Splicing - Major Pathway 179 | 179
Ion channel transport 177 | 177
Signaling by the B Cell Recept... 176 | 176
Regulation of expression of SL... 173 | 173
Programmed Cell Death 172 | 172
Interferon gamma signaling 171 | 171
Separation of Sister Chromatid... 170 | 170

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
C-type lectin domain family 6 member A CLEC6A Tbio Non-IDG -1.54098 33.3 328
Tyrosine-protein kinase SYK SYK Tchem Kinase -3.14835 1437.4 1136
C-type lectin domain family 4 member E CLEC4E Tbio Non-IDG -1.74401 58.6 164
C-type lectin domain family 4 member A CLEC4A Tbio Non-IDG -1.63402 48.8 197
C-type lectin domain family 4 member C CLEC4C Tbio Non-IDG -1.95327 82.4 140
Mucin-12 MUC12 Tbio Non-IDG -1.01744 9.74 60
Mucin-1 MUC1 Tbio Non-IDG -3.54835 3730.1 2598
Mucin-like protein 1 MUCL1 Tbio Non-IDG -1.68466 45.7 9
Tyrosine-protein kinase Fyn FYN Tclin Kinase -3.03132 1021.2 726
Mucin-15 MUC15 Tbio Non-IDG -1.51062 34.7 109